Literature DB >> 8377474

Bilateral uveitis in a rabbit experimentally infected with human T-lymphotropic virus type I.

H Taguchi1, T Sawada, A Fukushima, J Iwata, Y Ohtsuki, H Ueno, I Miyoshi.   

Abstract

BACKGROUND: Among the various diseases associated with human T-lymphotropic virus type I (HTLV-I) infection, HTLV-I-associated uveitis has been proposed as a distinct clinical entity. EXPERIMENTAL
DESIGN: Four rabbits experimentally infected with HTLV-I by blood transfusion from an HTLV-I-infected rabbit were observed for development of disease more than 3.5 years. Ophthalmologic, pathologic, hematologic, and virologic studies were performed on a rabbit that developed signs of uveitis.
RESULTS: One of four rabbits developed bilateral uveitis 3.5 years after infection with HTLV-I. Ophthalmologic examination revealed opacities of the anterior chamber, lens, and vitreous body, as well as ciliary injection. Histologic examination demonstrated marked thickening of Descemet's membrane with degeneration of the corneal endothelial cells and mononuclear cell infiltration in the iris and choroid. The normal structure of the retina was almost completely replaced by gliosis. Gene amplification of cells from the left anterior chamber by polymerase chain reaction using pX primers disclosed the presence of HTLV-I sequences and an HTLV-I producing cell line (UV-1) was established from cells of the right anterior chamber.
CONCLUSIONS: This is the first indication that rabbits may serve as an animal model of HTLV-I-related uveitis.

Entities:  

Mesh:

Year:  1993        PMID: 8377474

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

Review 1.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells.

Authors:  T Ohashi; S Hanabuchi; H Kato; Y Koya; F Takemura; K Hirokawa; T Yoshiki; Y Tanaka; M Fujii; M Kannagi
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).

Authors:  F Mortreux; M Kazanji; A S Gabet; B de Thoisy; E Wattel
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 4.  Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).

Authors:  J M Johnson; R Harrod; G Franchini
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

5.  The relationship between HTLV-I-infected cell lines and uveitis.

Authors:  A Fukushima; H Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-04       Impact factor: 3.117

6.  Enhanced replication of human T-cell leukemia virus type 1 in T cells from transgenic rats expressing human CRM1 that is regulated in a natural manner.

Authors:  Ryo Takayanagi; Takashi Ohashi; Eizaburo Yamashita; Yohei Kurosaki; Kumiko Tanaka; Yoshiyuki Hakata; Yasumasa Komoda; Satoru Ikeda; Yasuko Tsunetsugu-Yokota; Yuetsu Tanaka; Hisatoshi Shida
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

7.  Antigenic cross-reactivity between human T lymphotropic virus type I (HTLV-I) and retinal antigens recognized by T cells.

Authors:  A Fukushima; H Ueno; S Fujimoto
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

8.  Quantification of HTLV-I proviral load in experimentally infected rabbits.

Authors:  Tong-Mao Zhao; Bishop Hague; David L Caudell; R Mark Simpson; Thomas J Kindt
Journal:  Retrovirology       Date:  2005-05-23       Impact factor: 4.602

Review 9.  Animal Models Utilized in HTLV-1 Research.

Authors:  Amanda R Panfil; Jacob J Al-Saleem; Patrick L Green
Journal:  Virology (Auckl)       Date:  2013-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.